- Home
- CLDX vs XZO Comparison
CLDX vs XZO Comparison
Compare CLDX & XZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | XZO |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | XZO |
|---|---|---|
| Price | $29.00 | $15.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $44.50 | $27.00 |
| AVG Volume (30 Days) | ★ 813.3K | 188.9K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $97.61 | $56.84 |
| Revenue Next Year | $252.01 | $13.24 |
| P/E Ratio | ★ N/A | $18.63 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $14.40 | $12.92 |
| 52 Week High | $31.31 | $24.60 |
Technical Indicators
Market Signals| Indicator | CLDX | XZO |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 37.02 |
| Support Level | $24.70 | $13.91 |
| Resistance Level | $30.50 | $19.36 |
| Average True Range (ATR) | 1.52 | 1.25 |
| MACD | 0.78 | 0.16 |
| Stochastic Oscillator | 77.87 | 49.57 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About XZO Exzeo Group Inc.
Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.